Luu Brendan
Chief Business Officer
Luu Brendan has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 13, 2026.
On the most recent filing, Luu Brendan is listed as Chief Business Officer at ENANTA PHARMACEUTICALS INC. Inside the rolling window, Luu Brendan reported no open-market purchases and 1 open-market sale totaling $20K in ENTA.
Companies traded
Other insiders at ENTA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$20K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Luu Brendan made?
Luu Brendan has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Luu Brendan trade?
Luu Brendan has filed SEC Form 4 disclosures for 1 company, including ENTA.
When was Luu Brendan's most recent SEC Form 4 filing?
Luu Brendan's most recent SEC Form 4 filing on Tracefour is dated Feb 13, 2026.
What is Luu Brendan's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Luu Brendan is listed as Chief Business Officer.
What is Luu Brendan's total buy and sell value in the current window?
Inside the rolling retention window, Luu Brendan bought $0 and sold $20K based on SEC Form 4 filings.
What was Luu Brendan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,394 ENTA shares on 2025-12-05, worth $20K, per SEC Form 4 filings.